Home > Boards > US OTC > Medical - Healthcare >

Decision Diagnostics Corp. (DECN)

DECN RSS Feed
Add DECN Price Alert      Hide Sticky   Hide Intro
Moderator: pumper_stumper, ernie44, IPwatcher
Search This Board: 
Last Post: 5/19/2022 12:27:10 PM - Followers: 400 - Board type: Free - Posts Today: 0

 

     $DECN       
https://www.otcmarkets.com/stock/DECN/profile

                                                          

On December 18, 2020, the SEC and US Dept of Justice, announced actions against DECN due to alledged false claims about the supposed Covid-19 test being developed.

https://www.sec.gov/litigation/complaints/2020/comp-pr2020-327.pdf

On April 23, 2020, the SEC announced an action against DECN, suspending trading in the company's stock for two weeks.  There is currently a SEC court case ongoing where the SEC has identified the many reasons for the suspension.

https://www.otcmarkets.com/stock/DECN/news/SEC-Suspension-of-Trading?id=260085


Motion for Alternative Victim Notification Granted!

MINUTE ORDER granting the Government's 88 Motion for Victim Rights. The Government may provide notice to potential crime victims in this case through publication on a website maintained by the Department of Justice as an alternative to providing individualized notice. SO ORDERED. Signed by Judge Trevor N. McFadden on 3/17/2022.

ALTERNATIVE VICTIM NOTIFICATION PROCEDURES

The United States, through undersigned counsel, respectfully moves for authorization to use alternative victim notification procedures— namely, publication on a Department of Justice website—because the large number of potential crime victims in this case makes it impracticable to notify them on an individualized basis.

The website would provide a summary of the case, information regarding the case’s status, and other significant case-related documents, such as the charging documents. The website also would contain an e-mail address
and telephone number for a Victim Assistance Line through which individual potential crime victims could contact the Department of Justice with questions regarding the case.

https://www.justice.gov/criminal-vns/case/decision-diagnostics


 

DECN Earnings History

2021 Q1-Q3 - $1,374,707
  2020 - $
29,668,622-
2019 - $
3,132,295-
2018 - $2,240,220-
2017 - $2,991,404-
2016 - $2,967,357-
2015 - $2,771,345-
2014 - $1,841,010-

Total - $46,986,960-



                                     
Decision Diagnostics Corp. is a nationwide prescription and non-prescription diagnostics and home testing products distributor. We market our GenUltimate, GenSure, PetSure (test strips for dogs and cats) and GenChoice (in FDA 510(k) review), our panacea GenUltimate TBG glucose test strips and meter (in 3rd party testing), our GenPrecis test strips and meter (for private label sale), and our GenUltimate 4Pets glucose test strips and meter for the diabetic testing of dogs, cats and horses. We are also FDA approved and have complete R&D and manufacturing facilities in South Korea. We made the the first alternative glucose testing strips sold to the market in this decade and the first alternative test strip products sold into the market since early 2008.

                                                                                             
                                                                        



                                      

                                                                                                
               

Keith Berman, CEO of DECN commented, "GenViro for the Coronavirus (covid19) began as an outgrowth of our GenUltimate TBG product line. What makes the testing for the Coronavirus possible, and the GenUltimate TBG special, is the company's Impedance measurement technology.

https://www.frontiersin.org/articles/10.3389/fmicb.2015.00940/full

While infectious disease testing and management has not previously been a part of our business model, we seized on this "do good" opportunity because our "Gen" line of products are and have been manufactured since 2016 in what is ground zero for Coronavirus (covid19) in Daegu, Korea. The company will have available samples of the blood of those previously infected available for testing as the company quickly converts its GenUltimate TBG methods and Precise meter, into a precise infectious disease testing device for the screening for Coronavirus."

                                                    



Read Recent Press Releases » 

Review Recent Financial Reports »

Visit PharmaTech Solutions, Inc. »

                                 

 


Mod Cash4 Updated Ibox 3/11/2020

NEWS
https://www.otcmarkets.com/stock/DECN/news


 

GenViro! 12-Month Forecast

Number of Months

1

2

3

4

5

6

7

8

9

10

11

12

SUM

Year 1

Apr-20

May-20

Jun-20

Jul-20

Aug-20

Sep-20

Oct-20

Nov-20

Dec-20

Jan-21

Feb-21

Mar-21

 
                           

New Facility Customers

0

0

0

0

0

5000

5000

5000

5000

5000

5000

5000

 

Retained Facilities

0

0

0

0

0

0

5000

10000

15000

20000

25000

30000

 

Total Facility Customers

0

0

0

0

0

5000

10000

15000

20000

25000

30000

35000

35,000

Kits Consumed

0

0

0

0

0

15,000,000

30,000,000

45,000,000

60,000,000

75,000,000

90,000,000

105,000,000

420,000,000

We are not resting our laurels with our GenViro development. Later product entries will be test methods for Polio, Ebola (Marburg), Bird Flu, and SARS. The cost of our test kits will be sold in a price range of $4.95 to $7.95 per use. The Coronavirus kit will be sold for $6.95. Each kit sold will carry enough diagnostic for two tests, a primary test, and a test in reserve in case of human error in administrating the primary test. We plan to provide our diagnostics initially for use at hospitals, doctors' offices, and clinics. Once production ramps up, we will offer testing kits and meters to patients for testing at-home.

Mr. Berman concluded, "As you might imagine with a product announcement of such importance, we have been contacted by a number of potential partners for our kit, as well as companies who were not chosen last time to proceed past the proposition stage. The company's first choice for partnering will be a company that made "the cut" last time for our GenUltimate! TBG product. We will discuss partnering potential in a coming release. For the moment, the company is content calling on big box and long term care chains through its existing distributors and agents."

DECN also markets its PetSure! test strip for the diabetic testing of dogs and cats, a diagnostic specifically designed to run on the market leding Zoetis Alpha Trak meter system as well as the GenUltimate! 4Pets Test strip and Avantage! meter. The company has also just introduced its GenExpidient! Universal Translator for bio-sensor devices of different manufacture. A GenExpidient! device will be included in every Covid19 kit. Having such a device will lower the incidence of cleaning and disinfecting the GenViro! meter.

ABOUT DECISION DIAGNOSTICS CORP

Decision  

Forward-Looking Statements:

This release contains the company's forward-looking statements which are based on management's current expectations and assumptions as of March 11 2020, regarding the company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.

CONTACT INFORMATION:

Decision Diagnostics Corp.
Keith Berman (805) 446-2973

info@decisiondiagnostics.co
www.genultimate.com
www.genultimatetbg.com
www.petsureteststrips.com
www.pharmatechdirect.com

SOURCE: Decision Diagnostics Corp.



View source version on accesswire.com:
https://www.accesswire.com/579985/DECN-Provides-First-Looks-At-Its-GenViroTM-Corona-Virus-Screening-Kit-First-Year-Product-Forecast-of-420-Million-Kits-with-Sales-Beginning-Late-3Q-2020


 

SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device
FOR IMMEDIATE RELEASE

2020-327

Washington D.C., Dec. 18, 2020 —
The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics' securities on April 23, 2020.

The SEC's complaint alleges that Decision Diagnostics and Berman seized upon the global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood test that could detect Covid-19 in less than a minute. According to the complaint, from March 2020 to at least June 2020, Decision Diagnostics and Berman made false and misleading statements about the existence of Decision Diagnostics' Covid-19 device and progress towards FDA emergency use authorization. As alleged, at the time of these claims, Decision Diagnostics lacked a proven method for detecting the virus and had no physical testing device. Further, its advisors had warned that the testing kit they were trying to manufacture would not work as Decision Diagnostics had described. The complaint also alleges that the statements created the misleading impression that the test was soon to be introduced to the market and led to surges in the price and trading volume of Decision Diagnostics' stock.

"During this unprecedented time, when the need for truthful disclosures concerning Covid-19 tests is of vital importance, Decision Diagnostics and its CEO allegedly misled investors by claiming to have made a working test device when all they had was an idea that had not materialized into a product," said Stephanie Avakian, Director of the Division of Enforcement. "With the onset of the global pandemic, we quickly pivoted to identify potential areas of fraud. This case is another example of how the Commission will hold accountable those who exploit the pandemic to harm investors."

"In our complaint, we allege that Decision Diagnostics and Berman repeatedly made baseless representations to the investing public about market-moving events like progress in obtaining FDA approval and having breakthrough technology," said Anita B. Bandy, Associate Director of the Division of Enforcement. "Today's filing is a credit to the dedicated SEC staff, who continued to investigate after the trading suspension and quickly uncovered the alleged fraud."

The complaint, filed in the U.S. District Court for the Southern District of New York, charges Decision Diagnostics and Berman with violating antifraud provisions of the securities laws. The SEC is seeking a court order permanently enjoining both Decision Diagnostics and Berman from directly or indirectly violating those provisions and ordering them to pay civil penalties.

The Department of Justice's Market Integrity and Major Frauds Unit announced today that parallel criminal charges against Berman were also filed in the U.S. District Court for the District of Columbia.

The SEC's investigation, which is continuing, has been conducted by Ernesto Amparo, Carlisle Perkins and Lesley Atkins and supervised by Jeff Leasure and Ms. Bandy with invaluable assistance by Margaret A. Cain of the Office of Market Intelligence and Hane L. Kim of the Microcap Fraud Task Force, both members of the SEC's Coronavirus Steering Committee. The litigation will be handled by James Carlson, David Misler and supervised by Tom Bednar. The SEC appreciates the assistance of the Financial Industry Regulatory Authority.

https://www.sec.gov/news/press-release/2020-327

https://www.sec.gov/litigation/09/complaints/2020/comp-pr2020-327.pdf

 
DECN SECURITY DETAILS

Share Structure

 
Authorized Shares
494,995,000
 
Outstanding Shares

02/14/22 - 380,486,143
11/12/21 - 358,500,583
09/30/21 - 357,780,503
12/17/20 - Berman arrested by FBI

12/11/20 - 349,741,793
11/06/20 - 332,025,278
10/09/20 - 325,752,685
09/11/20 -  313,434,787
08/07/20 - 305,063,608
07/10/20 - 302,663,608
05/15/20 - 267,213,123
04/03/20 - 212,000,000
03/31/20 - 199,792,833
03/06/20 - 159,999,161
12/31/19 - 156,679,161
12/31/18 - 134,551,840
12/31/17 - 110,241,640
12/31/16 - 84,639,908 

 
 
Restricted

07/10/2020 - 5,969,436
10/09/2020 - 9,983,981
12/10/2021 - 18,742,771
 
Unrestricted
12/10/2021 - 339,757,812
02/15/2022 - 361,025,480
 

 

 
 
 
DECN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#96655  Sticky Note Motion for Alternative Victim Notification Granted! pumper_stumper 03/18/22 08:46:31 AM
#94285  Sticky Note LINKS TO COURT DOCUMENTS IN BERMAN/DECN SECURITIES FRAUD PROCEEDINGS: IPwatcher 01/16/21 08:53:26 PM
#96727   I guess he doesn’t know that clinical trials Johnny_C 05/19/22 12:27:10 PM
#96726   Omg, is there anything in Bozo Berman’s press Johnny_C 05/19/22 12:25:40 PM
#96725   My money says they took away a "few" I ll be back 05/19/22 11:01:59 AM
#96724   Interesting! We will NEVER find out as the snake IPwatcher 05/19/22 10:53:00 AM
#96723   Interesting! We will NEVER find out as the snake I ll be back 05/19/22 09:38:51 AM
#96722   LICGO litigation settled our of court. IPwatcher 05/19/22 05:01:59 AM
#96721   true enough----- things remain LQQKING ''BAAAAAAAD'' ernie44 05/18/22 09:36:49 AM
#96720   It seems like a pretty easy clinical IPwatcher 05/17/22 06:20:49 PM
#96719   Basically, Berman would have to try and show IPwatcher 05/17/22 06:16:53 PM
#96718   Maybe they can hire the losers to be PlutoniumImplosion07 05/17/22 03:33:49 PM
#96717   No offense but a lot of this stuff PlutoniumImplosion07 05/17/22 03:30:58 PM
#96716   During hard times and a looming recession---people turn ernie44 05/16/22 05:07:53 PM
#96715   If this actually goes to trial, Berman has IPwatcher 05/16/22 01:26:52 PM
#96714   BERMAN can't be that stupid ----he will just ernie44 05/15/22 06:56:46 PM
#96713   If this actually goes to trial, Berman has PlutoniumImplosion07 05/15/22 03:42:59 PM
#96712   That sounds like a lot of fun. The PlutoniumImplosion07 05/14/22 03:12:35 PM
#96710   You should join us in Washington for the Johnny_C 05/12/22 10:00:41 PM
#96709   Well, it is a good thing he didn’t Johnny_C 05/11/22 02:21:30 AM
#96708   You're being too harsh on him. This sounds PlutoniumImplosion07 05/10/22 09:25:00 PM
#96707   Classic tale of an investors visit with our pumper_stumper 05/10/22 12:36:18 PM
#96706   Did you ever invest yourself? PlutoniumImplosion07 05/04/22 04:59:31 PM
#96705   And to think the Bozo Bermanites ridiculed me Johnny_C 05/04/22 08:30:01 AM
#96704   Today was the lowest close of 2022 for pumper_stumper 05/03/22 08:57:27 PM
#96702   DECN officially designated as Dark or Defunct, AND pumper_stumper 05/02/22 09:45:26 AM
#96701   This, and the lack of required financial filings pumper_stumper 05/01/22 10:55:14 AM
#96700   the train is coming to a station near ernie44 04/30/22 01:00:33 PM
#96698   Sure was a long slow crawl to the IPwatcher 04/27/22 08:14:44 PM
#96697   Sure was a long slow crawl to the Johnny_C 04/27/22 05:32:23 PM
#96696   You can't have a corporation cease corporate IPwatcher 04/27/22 11:01:03 AM
#96695   this Berman guy is a real BOTTOM LOWLIFE TROLL ernie44 04/26/22 11:53:03 AM
#96694   HAPPY ANNIVERSARY, MF BERMAN! Hopefull17 04/23/22 02:47:16 PM
#96693   I kind of thought that Berman is working Johnny_C 04/18/22 10:08:10 PM
#96690   I'll bet KB didn't see this coming. I ll be back 04/15/22 10:19:53 PM
#96689   Recently read that blood is a top 5 Johnny_C 04/15/22 12:31:13 AM
#96688   I think Judge McFadden is handling many Jan Johnny_C 04/06/22 05:22:56 PM
#96687   I'd consider donating blood or some other organs Hopefull17 04/04/22 10:36:43 AM
#96685   I think a succession plan is necessary. You PlutoniumImplosion07 04/02/22 09:28:23 PM
#96684   I doubt Bozo Berman overusing his wrist during Johnny_C 04/01/22 04:08:47 PM
#96683   Anyone think it is possible Berman hurt himself, IPwatcher 04/01/22 02:38:28 PM
#96682   Delayed Financials! Predictable Keith strikes again! pumper_stumper 03/31/22 05:19:58 PM
#96681   Anyone think it is possible Berman hurt himself, pumper_stumper 03/30/22 06:36:20 PM
#96680   If it was medical related wouldn't Bozo have pumper_stumper 03/30/22 08:26:08 AM
#96679   PR #8 Happy 2 Year Anniversary to Keith pumper_stumper 03/29/22 02:41:48 PM
#96676   An 8 month move is not a normal pumper_stumper 03/26/22 06:29:04 PM
#96675   I tried to tell you, continuances are the Johnny_C 03/26/22 05:24:35 PM
#96674   Unbelievable! There wasn't even a motion filed pumper_stumper 03/26/22 11:44:41 AM
#96673   This bastard, MF Berman, will die of old Hopefull17 03/26/22 11:32:29 AM
#96672   I thought you were the charter member of pumper_stumper 03/26/22 10:37:41 AM
#96671   That press release made it official! 525 Johnny_C 03/26/22 10:14:24 AM
#96669   PR #7 Happy 2 Year Anniversary to Keith pumper_stumper 03/25/22 10:53:05 AM
PostSubject
Consent Preferences